You will be told your investments are going to multi-bag and you will live happily ever after. It sounds cynical but with the Alternative Investment Market now home to
Candlestick Patterns – Doji – help identify short-term price moves.
In this article, we will be discussing candlestick patterns, in particular, Doji, and how they help identify short-term price moves. We will begin with specifying candlestick structure followed by the
AIM companies to be required to apply a recognised corporate governance code
This week London Stock Exchange has announced that all AIM companies will be required to apply a recognised corporate governance code from 28th September 2018.
AIM companies now exempt from maintaining insider lists under the Market Abuse Regulation
MiFID II came into force on 3 January 2018. Among other things, this EU directive establishes the SME Growth Market concept. The European Commission hopes that this new market classification
What is Blockchain? This video is an introduction to blockchain technology:
With the rapid surge in the price of Bitcoin has brought the discussion on cryptocurrencies and distributed ledger technologies (DLT) into the mainstream. But why all the hype? Before
Evolution of an Investor – Part 1 of 5 by WheelieDealer
By @wheeliedealer This Blog, the first of a Series, has had a pretty slow development from a simple observation about how many people I see/know go about their
Southeast Asia: An Emerging Market With Booming Digital Growth
When it comes to economic growth in Asia, the focus often falls on China. However, while China’s story is continually staggering in its scale, the Chinese economic powerhouse is
What is waiting for you on today’s AIM Market – Will you survive?
A hatchling marine iguana stands perilously close to a hunting Galapagos racer snake If you haven’t already seen this amazing clip from the series of Planet Earth you should. It will
Thanks for using lse.co.uk
Scott, a Team Member/Director at London South East, with a simple message of thanks to round out 2017 and the
EXCLUSIVE: HemoGenyx are creating blood cancer treatments with US$9 billion market potential
#HEMO are a London-listed, US-based biotech company developing two revolutionary blood cancer treatments. CDX antibodies are intended to remove the need
RNS VIDEO: Reabold Resources #RBD raise £6 million and take stake in Danube Petroleum
Reabold Resources Co-Chief Executives Stephen Williams and Sachin Oza have just successfully raised ‘approximately six million pounds’ to invest in
#PHARMA: Therapix Biosciences are developing ‘medicinal cannabis’ for Tourette’s and sleep apnea
Josh Blacher, CFO at Therapix Biosciences, describes how his company are developing a therapeutic approach to obstructive sleep apnea, and
